| Q63225367 | Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease |
| Q55499802 | Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family. |
| Q40981694 | Calcium-dependent activation of transglutaminase 2 by nanosecond pulsed electric fields |
| Q41975551 | Carbon monoxide modulates alpha-smooth muscle actin and small proline rich-1a expression in fibrosis |
| Q28260600 | Cellular functions of tissue transglutaminase |
| Q39697142 | Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy |
| Q51907616 | Deletion of 8q24 in an adult with mild dysmorphic features, developmental delay, and ketotic hypoglycemia. |
| Q60935810 | Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients |
| Q37907975 | Evidences for a role of protein cross-links in transglutaminase-related disease. |
| Q39442011 | Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer |
| Q37186873 | Extracellular matrix modifications at fertilization: regulation of dityrosine crosslinking by transamidation |
| Q36879220 | Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer |
| Q40041960 | GTP-binding-defective forms of tissue transglutaminase trigger cell death |
| Q33289840 | Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells |
| Q39330237 | Interplay between transglutaminases and heparan sulphate in progressive renal scarring |
| Q33476870 | Intracellular localization and conformational state of transglutaminase 2: implications for cell death |
| Q81710167 | More than two sides of a coin? How to detect the multiple activities of type 2 transglutaminase |
| Q60950274 | Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity |
| Q33661950 | Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation |
| Q28247511 | Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein |
| Q37700761 | Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis |
| Q36620140 | Regulation of the activities of the mammalian transglutaminase family of enzymes |
| Q54600809 | Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix. |
| Q28262529 | Role of transglutaminase 2 in celiac disease pathogenesis |
| Q37124999 | Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1 |
| Q90278106 | TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma |
| Q34219975 | TGM2: a cell surface marker in esophageal adenocarcinomas. |
| Q36884822 | The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability. |
| Q41418352 | The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase |
| Q64249805 | The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression |
| Q87593562 | The diamond anniversary of tissue transglutaminase: a protein of many talents |
| Q91938329 | Tissue Transglutaminase Promotes Early Differentiation of Oligodendrocyte Progenitor Cells |
| Q47099586 | Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures |
| Q36916874 | Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling |
| Q36503511 | Tissue transglutaminase: a new target to reverse cancer drug resistance |
| Q42403952 | Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization |
| Q28069852 | Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death |
| Q39786229 | Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells |
| Q33522235 | Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes |
| Q35693361 | Transglutaminase 2: a molecular Swiss army knife |
| Q30155456 | Transglutaminase 6: a protein associated with central nervous system development and motor function |
| Q37352964 | Transglutaminase activation in neurodegenerative diseases. |
| Q38269678 | Transglutaminase as a therapeutic target for celiac disease |
| Q44811427 | Transglutaminases: future perspectives. |
| Q34775357 | Type 2 transglutaminase in Huntington’s disease: a double‐edged sword with clinical potential |
| Q38879949 | miR-19-Mediated Inhibition of Transglutaminase-2 Leads to Enhanced Invasion and Metastasis in Colorectal Cancer |